Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 29

Sort by

Sort Order Select

Journal Articles

A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis–Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes

Gabriele Sassi, Giada Licata, Giuliana Ventriglia, Amber Wouters, Pierre Lemaitre, Ruth Seurinck, Alessia Mori, Giuseppina Emanuela Grieco, Samal Bissenova, Darcy Ellis, Silvia Caluwaerts, Pieter Rottiers, Niels Vandamme, Chantal Mathieu, Francesco Dotta, Conny Gysemans, Guido Sebastiani

Diabetes 2023;72(10):1470–1482

https://doi.org/10.2337/db22-0852

Published: 26 July 2023

View article titled, A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis–Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes

Meeting Abstracts

295-OR: Mechanisms of Antigen-Specific Immunotherapy following Tolerance Induction to a CD4 Hybrid Insulin Peptide Epitope and the Impact on CD8 T Cell Dysfunction

JAMES E. DILISIO, ROCKY L. BAKER, KATHRYN M. HASKINS

Diabetes 2023;72(Supplement_1):295-OR

https://doi.org/10.2337/db23-295-OR

Published: 20 June 2023

View article titled, 295-OR: Mechanisms of Antigen-Specific Immunotherapy following Tolerance Induction to a CD4 Hybrid Insulin Peptide Epitope and the Impact on CD8 T Cell Dysfunction

Meeting Abstracts

182-OR: C-Peptide and Metabolic Outcomes in Immunotherapy Studies of New-Onset Type 1 Diabetes

PETER TAYLOR, KIMBERLY S. COLLINS, STEPHEN KARPEN, ELNAZ ATABAKHSH, SIMI AHMED, MARJANA MARINAC, ESTHER LATRES, ANNA LAM, PETER A. SENIOR, MARK RIGBY, PETER GOTTLIEB, COLIN DAYAN

Diabetes 2023;72(Supplement_1):182-OR

https://doi.org/10.2337/db23-182-OR

Published: 20 June 2023

View article titled, 182-OR: C-Peptide and Metabolic Outcomes in Immunotherapy Studies of New-Onset Type 1 Diabetes

Journal Articles

Immunotherapy With Low-Dose IL-2/CD25 Prevents β-Cell Dysfunction and Dysglycemia in Prediabetic NOD Mice

Farhan M. Qureshi, Julia K. Panzer, Janika Põder, Thomas R. Malek, Alejandro Caicedo

Diabetes 2023;72(6):769–780

https://doi.org/10.2337/db22-0482

Published: 20 March 2023

View article titled, Immunotherapy With Low-Dose IL-2/CD25 Prevents β-Cell Dysfunction and Dysglycemia in Prediabetic NOD Mice

Journal Articles

Comment on Liu et al. Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 Diabetes. Diabetes 2022;71:722–732

Asimina Petsiou, George Vartholomatos, Agathocles Tsatsoulis, George K. Papadopoulos

Diabetes 2022;71(12):e20–e21

https://doi.org/10.2337/db22-0584

Published: 21 November 2022

View article titled, Comment on Liu et al. Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 Diabetes. Diabetes 2022;71:722–732

Journal Articles

Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 Diabetes

Yuk-Fun Liu, Jake Powrie, Sefina Arif, Jennie H.M. Yang, Evangelia Williams, Leena Khatri, Mamta Joshi, Loic Lhuillier, Nikolaos Fountoulakis, Emma Smith, Craig Beam, Anna Lorenc, Mark Peakman, Timothy Tree

Diabetes 2022;71(4):722–732

https://doi.org/10.2337/db21-0728

Published: 24 January 2022

View article titled, Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 Diabetes

Journal Articles

The SAgA of Antigen-Specific Immunotherapy for Type 1 Diabetes

Roberto Mallone, Sylvaine You

Diabetes 2021;70(6):1247–1249

https://doi.org/10.2337/dbi21-0011

Published: 02 July 2021

View article titled, The SAgA of Antigen-Specific Immunotherapy for Type 1 Diabetes

Meeting Abstracts

1138-P: Diabetes Induced by Immunotherapy

DUCHDA VY

Diabetes 2021;70(Supplement_1):1138-P

https://doi.org/10.2337/db21-1138-P

Published: 01 June 2021

View article titled, 1138-P: Diabetes Induced by Immunotherapy

Meeting Abstracts

60-LB: Dendritic Cells Engineered with Tailored Multiepitopes-Encoding mRNA as Precision Medicine for Immunotherapy of Type 1 Diabetes

REBUMA FIRDESSA FITE, REMI J. CREUSOT

Diabetes 2021;70(Supplement_1):60-LB

https://doi.org/10.2337/db21-60-LB

Published: 01 June 2021

View article titled, 60-LB: Dendritic Cells Engineered with Tailored Multiepitopes-Encoding mRNA as Precision Medicine for Immunotherapy of Type 1 Diabetes

Journal Articles

How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?

Michael J. Haller, Laura M. Jacobsen, Amanda L. Posgai, Desmond A. Schatz

Diabetes 2021;70(5):1021–1028

https://doi.org/10.2337/dbi20-0045

Published: 25 February 2021

View article titled, How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?

Meeting Abstracts

66-LB: Combined Immunotherapy with T Regulatory Cells and Anti-CD20 Antibody Prolongs Survival of Pancreatic Islets in Type 1 Diabetes

MACIEJ ZIELINSKI, MAGDALENA ZALINSKA, DOROTA IWASZKIEWICZ-GRZES, MATEUSZ GLIWINSKI, MATYLDA HENNIG, ANNA JAZWINSKA-CURYLLO, HALLA KAMINSKA, JUSTYNA SAKOWSKA, RADOSLAW OWCZUK, WOJCIECH MLYNARSKI, PRZEMYSLAWA JAROSZ-CHOBOT, ARTUR BOSSOWSKI, AGNIESZKA SZADKOWSKA, JANUSZ SIEBERT, MALGORZATA MYSLIWIEC, NATALIA M. MAREK-TRZONKOWSKA, PIOTR TRZONKOWSKI

Diabetes 2020;69(Supplement_1):66-LB

https://doi.org/10.2337/db20-66-LB

Published: 01 June 2020

View article titled, 66-LB: Combined Immunotherapy with T Regulatory Cells and Anti-CD20 Antibody Prolongs Survival of Pancreatic Islets in Type 1 Diabetes

Journal Articles

Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?

Rémi J. Creusot, Jorge Postigo-Fernandez, Nato Teteloshvili

Diabetes 2018;67(8):1481–1494

https://doi.org/10.2337/db17-1564

Published: 13 July 2018

View article titled, Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?

Includes: Supplementary data

Journal Articles

In This Issue of Diabetes

Diabetes 2018;67(8):1455–1456

https://doi.org/10.2337/db18-ti08

Published: 13 July 2018

View article titled, In This Issue of Diabetes

Meeting Abstracts

Euglycemic DKA as an Initial Presentation of Immunotherapy-Induced Insulin-Dependent Diabetes

PRIYANKA IYER, SONALI N. THOSANI

Diabetes 2018;67(Supplement_1):1195-P

https://doi.org/10.2337/db18-1195-P

Published: 01 July 2018

View article titled, Euglycemic DKA as an Initial Presentation of Immunotherapy-Induced Insulin-Dependent Diabetes

Meeting Abstracts

The MultiPepT1De Study—Examining the Safety of Peptide Immunotherapy Using Multiple Islet Antigens in Recent-Onset Type 1 Diabetes

YUK-FUN LIU, JAKE K. POWRIE, SEFINA ARIF, NIKOLAOS FOUNTOULAKIS, MAMTA JOSHI, EMMA L. SMITH, FOTEINI STRIMENOPOULOU, MOIRA THOMSON, MARK PEAKMAN

Diabetes 2018;67(Supplement_1):1733-P

https://doi.org/10.2337/db18-1733-P

Published: 01 July 2018

View article titled, The MultiPepT1De Study—Examining the Safety of Peptide Immunotherapy Using Multiple Islet Antigens in Recent-Onset Type 1 Diabetes

Journal Articles

Insulitis Revisited

Bart O. Roep

Diabetes 2016;65(3):545–547

https://doi.org/10.2337/dbi15-0040

Published: 13 February 2016

View article titled, Insulitis Revisited

Journal Articles

Alternative Approach to Immunomodulation for Type 1 Diabetes: Antigen-Specific Immunotherapy In Utero

Parth Narendran

Diabetes 2015;64(10):3347–3349

https://doi.org/10.2337/db15-0825

Published: 16 September 2015

View article titled, Alternative Approach to Immunomodulation for Type 1 Diabetes: Antigen-Specific Immunotherapy In Utero

Journal Articles

Of Bugs and Men: Antigen-Fortified Lactoccoccus lactis for Type 1 Diabetes Immunotherapy

Roberto Mallone, Slobodan Culina

Diabetes 2014;63(8):2603–2605

https://doi.org/10.2337/db14-0587

Published: 17 July 2014

View article titled, Of Bugs and Men: Antigen-Fortified Lactoccoccus lactis for Type 1 Diabetes Immunotherapy

Journal Articles

In This Issue of Diabetes

Diabetes 2014;63(6):1821–1822

https://doi.org/10.2337/db14-ti06

Published: 15 May 2014

View article titled, In This Issue of Diabetes

Journal Articles

Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials

Teodora P. Staeva, Lucienne Chatenoud, Richard Insel, Mark A. Atkinson

Diabetes 2013;62(1):9–17

https://doi.org/10.2337/db12-0562

Published: 13 December 2012

View article titled, Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials

NARROW

A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis–Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes

295-OR: Mechanisms of Antigen-Specific Immunotherapy following Tolerance Induction to a CD4 Hybrid Insulin Peptide Epitope and the Impact on CD8 T Cell Dysfunction

182-OR: C-Peptide and Metabolic Outcomes in Immunotherapy Studies of New-Onset Type 1 Diabetes

Immunotherapy With Low-Dose IL-2/CD25 Prevents β-Cell Dysfunction and Dysglycemia in Prediabetic NOD Mice

Comment on Liu et al. Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 Diabetes. Diabetes 2022;71:722–732

Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 Diabetes

The SAgA of Antigen-Specific Immunotherapy for Type 1 Diabetes

1138-P: Diabetes Induced by Immunotherapy

60-LB: Dendritic Cells Engineered with Tailored Multiepitopes-Encoding mRNA as Precision Medicine for Immunotherapy of Type 1 Diabetes

How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?

66-LB: Combined Immunotherapy with T Regulatory Cells and Anti-CD20 Antibody Prolongs Survival of Pancreatic Islets in Type 1 Diabetes

Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?

In This Issue of Diabetes

Euglycemic DKA as an Initial Presentation of Immunotherapy-Induced Insulin-Dependent Diabetes

The MultiPepT1De Study—Examining the Safety of Peptide Immunotherapy Using Multiple Islet Antigens in Recent-Onset Type 1 Diabetes

Insulitis Revisited

Alternative Approach to Immunomodulation for Type 1 Diabetes: Antigen-Specific Immunotherapy In Utero

Of Bugs and Men: Antigen-Fortified Lactoccoccus lactis for Type 1 Diabetes Immunotherapy

In This Issue of Diabetes

Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only